MedPath

UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER

🇺🇸United States
Ownership
-
Established
1943-01-01
Employees
8.1K
Market Cap
-
Website
http://www.utsouthwestern.edu

Non-Interventional F-Two Isoprostane Trial (NIFTI)

Completed
Conditions
Traumatic Brain Injury
First Posted Date
2007-07-25
Last Posted Date
2020-03-16
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
50
Registration Number
NCT00505908
Locations
🇺🇸

Parkland Memorial Hospital, Dallas, Texas, United States

Efficacy of Pramlintide on Prevention of Weight Gain Early Onset of Type 1 Diabetes

Phase 4
Withdrawn
Conditions
Type 1 Diabetes
Interventions
First Posted Date
2007-07-25
Last Posted Date
2019-01-08
Lead Sponsor
University of Texas Southwestern Medical Center
Registration Number
NCT00505882
Locations
🇺🇸

UT Southwestern at Dallas, Dallas, Texas, United States

Lipid, Glycemic, and Insulin Responses to Meals Rich in Different Fatty Acids

Not Applicable
Completed
Conditions
Type 2 Diabetes Mellitus
First Posted Date
2007-05-28
Last Posted Date
2007-05-28
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
11
Registration Number
NCT00479791
Locations
🇺🇸

UT Southwestern Medical Center at Dallas, Dallas, Texas, United States

Pharmacokinetic Response to BPI in Burns

Phase 2
Terminated
Conditions
Burns
Interventions
First Posted Date
2007-04-19
Last Posted Date
2019-11-20
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
4
Registration Number
NCT00462904
Locations
🇺🇸

UT Southwestern Medical Center, Dallas, Texas, United States

Therapeutic Approaches to HAART-Induced Lipodystrophy

Phase 2
Completed
Conditions
HIV Infections
Lipodystrophy
Interventions
Other: Placebo
First Posted Date
2007-04-18
Last Posted Date
2019-05-09
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
23
Registration Number
NCT00461552
Locations
🇺🇸

UT Southwestern Medical Center, Dallas, Texas, United States

Comparison of Efficacy and Safety of Ezetimibe or Statin Monotherapy to Co-Administration of Both

Not Applicable
Completed
Conditions
Cholesterol, LDL
First Posted Date
2007-04-18
Last Posted Date
2007-04-18
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
240
Registration Number
NCT00461968
Locations
🇺🇸

UT Southwestern Medical Center at Dallas, Dallas, Texas, United States

Novel Therapies for Metabolic Complications of Lipodystrophies

Not Applicable
Completed
Conditions
Insulin Resistance
Diabetes
Hepatic Steatosis
Hypertriglyceridemia
Interventions
Other: low-fat diet ( Still recruiting )
Other: Diet
First Posted Date
2007-04-09
Last Posted Date
2018-10-16
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
4
Registration Number
NCT00457938
Locations
🇺🇸

UT Southwestern Medical Center, Dallas, Texas, United States

Mechanisms of Lipodystrophy in HIV-Infected Pateints

Phase 4
Completed
Conditions
HIV Infections
Interventions
First Posted Date
2007-04-06
Last Posted Date
2019-07-18
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
56
Registration Number
NCT00457665
Locations
🇺🇸

University of Texas Southwestern Medical Center, Dallas, Texas, United States

Cholic Acid for Hepatic Steatosis in Lipodystrophy

Phase 2
Completed
Conditions
Hepatic Steatosis
Interventions
First Posted Date
2007-04-06
Last Posted Date
2019-01-17
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
18
Registration Number
NCT00457639
Locations
🇺🇸

University of Texas Southwestern Medical Center, Dallas, Texas, United States

Quetiapine for Bipolar Disorder and Alcohol Dependence

Phase 4
Completed
Conditions
Bipolar Disorder
Alcohol Dependence
Interventions
Drug: Placebo
First Posted Date
2007-04-06
Last Posted Date
2016-04-05
Lead Sponsor
University of Texas Southwestern Medical Center
Target Recruit Count
90
Registration Number
NCT00457197
Locations
🇺🇸

Psychoneuroendocrine Research Program, Dallas, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath